(Q48581295)

13 February 2018

title

Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. (English)

1 reference

13 February 2018

main subject

obstructive sleep apnea

1 reference

Toshiyuki Tazaki

1

1 reference

13 February 2018

Kenji Minoguchi

2

1 reference

13 February 2018

Takuya Yokoe

3

1 reference

13 February 2018

Karen Thursday R Samson

4

1 reference

13 February 2018

Hideko Minoguchi

5

1 reference

13 February 2018

Akihiko Tanaka

6

1 reference

13 February 2018

Yoshio Watanabe

7

1 reference

13 February 2018

Mitsuru Adachi

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

10 September 2004

1 reference

13 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

13 February 2018

volume

170

1 reference

13 February 2018

issue

12

1 reference

13 February 2018

page(s)

1354-1359

1 reference

13 February 2018

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Elevated C-reactive protein in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Phenotypic and Functional Characterization of Blood γδ T Cells in Sleep Apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-193OC

10.1164/RCCM.200402-193OC

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018